iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit

NASHUA, N.H., March 26, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief Executive Officer, and Stacey Stevens, Chief Strategy & Commercial Officer, will be present a corporate overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit, being held March 27 in New York City.

About iCAD, Inc. 
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com. 

Contact:

Investor Relations:
LifeSci Advisors
Jeremy Feffer
(212) 915-2568
jeremy@lifesciadvisors.com

or:

Media Inquiries:
ARPR, on behalf of iCAD, Inc.
Paul Barren
(855) 300-8209
paul@arpr.com